Cheng-yu Hung
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Source-specific Control Leverage for Reducing Oxidative Potential of PM2.5 Revealed by Explainable Machine Learning.
Journal: Environmental pollution (Barking, Essex : 1987)
Published: March 14, 2026
Higher hemoglobin is associated with better survival in coronary artery disease, heart failure with reduced ejection fraction, and chronic kidney disease.
Journal: American heart journal plus : cardiology research and practice
Published: May 16, 2025
Metabolic profiling of amniotic fluid by differential 12C-/13C-isotope dansylation labeling LC-MS for application in trisomy 21 fetuses.
Journal: Metabolomics : Official journal of the Metabolomic Society
Published: November 13, 2024
Enhanced nano-LC-MS for analyzing dansylated oral cancer tissue metabolome dissolved in solvents with high elution strength.
Journal: Analytica chimica acta
Published: August 29, 2024
Growth-dependent concentration gradient of the oscillating Min system in Escherichia coli.
Journal: The Journal of cell biology
Published: June 18, 2024
ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells.
Journal: International journal of molecular sciences
Published: April 13, 2024
Aspartate and Acetate Fuel Gastrointestinal Stromal Tumors Beyond the Warburg Effect.
Journal: Annals of surgery open : perspectives of surgical history, education, and clinical approaches
Published: April 25, 2022
Development of a method for dansylation of metabolites using organic solvent-compatible buffer systems for amine/phenol submetabolome analysis.
Journal: Analytica chimica acta
Published: August 27, 2021
Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat.
Journal: International journal of molecular sciences
Published: February 04, 2021
Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines.
Journal: Biochemical pharmacology
Published: May 01, 2020
Last Updated: 09/26/2026